Kolkata-based ICMR-NICED has submitted a proposal to the Department of Biotechnology under the Union Ministry of Science and Technology for research on an oral COVID vaccine, a senior official of the institute said on Monday.
The proposed research project will be done in collaboration with a German firm and it has been shortlisted for presentation, she said.
"We have submitted a proposal for research on an oral vaccine. It will be carried out in collaboration with a German firm. Work can be started once it gets selected and funded," ICMR-NICED Director Shanta Dutta said.
She said it will take around 5-6 years to develop the oral vaccine in a laboratory.
Once the oral vaccine is developed, it will first be tested on animals as is done for all vaccines, Dutta said.
"All stages of developing a vaccine, and phases of clinical trials for safety and immunogenicity will be followed in this case too and the vaccine will be first tested on animals.
"The entire process will take at least five to six years and we can expect the oral vaccine in the market only after that," she added.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)